Izotropic Corporation (CSE:IZO)

Market Cap	21.61M
Revenue (ttm)	n/a
Net Income (ttm)	-2.31M
Shares Out	67.53M
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	41,308
Average Volume	31,327
Open	0.3050
Previous Close	0.3050
Day's Range	0.3050 - 0.3200
52-Week Range	0.0350 - 0.4900
Beta	2.28
RSI	39.55
Earnings Date	Dec 30, 2025

About Izotropic

Izotropic Corporation, a research and development company, develops diagnostic products for detecting breast cancers. The company develops and commercializes IzoView, a CT diagnostic imaging device with a platform of targeted uses offering high resolution, true 3D dedicated breast imaging with 360‐degree image acquisition and can be used with or without injectable contrast. Izotropic Corporation was incorporated in 2016 and is headquartered in Surrey, Canada.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2016
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: IZO